Current report filing


May 13, 2022
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description On May 18, 2022, 22nd Century Group, Inc. (the “Company”), filed with the U.S. Securities and Exchange Commission a Current Report on Form 8-K (the “Original Form 8-K”) regarding the completion of the Company’s acquisition, on May 13, 2022, of substantially all of the assets of  GVB Biopharma’s (“GVB”)  business dedicated to hemp-based cannabinoid extraction, refinement, contract manufacturing and product development  (the “Transaction”).
Document Period End Date May 13, 2022
Entity File Number 001-36338
Entity Registrant Name 22nd Century Group, Inc.
Entity Central Index Key 0001347858
Entity Tax Identification Number 98-0468420
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 500 Seneca Street
Entity Address, Address Line Two Suite 507
Entity Address, City or Town Buffalo
Entity Address, State or Province NY
Entity Address, Postal Zip Code 14204
City Area Code 716
Local Phone Number 270-1523
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.00001 par value
Trading Symbol XXII
Security Exchange Name NASDAQ
Entity Emerging Growth Company false